ResMed boosts European presence with MAP purchase
This article was originally published in Clinica
Executive Summary
ResMed, which manufactures products for the diagnosis and treatment of sleep disorders, has bought German company MAP Medizin-Technologie for DM146 million ($69 million) in cash and debt assumption. The acquisition brings ResMed the market leader in Germany, the second largest market for sleep disordered breathing products in the world.